Concepedia

Publication | Open Access

Estimating the cost-effectiveness of an infant 13-valent pneumococcal conjugate vaccine national immunization program in China

DOIFull Paper Access

24

Citations

27

References

2018

Year

Kunling Shen, Matt Wasserman, Dongdong Liu, Yonghong Yang, Junfeng Yang, Gregory F. Guzauskas, Bruce C. M. Wang, Betsy Hilton, Raymond Farkouh
PLoS ONE

Abstract

Initiation of a PCV13 NIP in China incurs large upfront costs but is good value for money, and is likely to prevent substantial cases of disease among children and non-vaccinated individuals.

References

YearCitations

Page 1